Confluence Investment Management Reduces Stake in CONMED Corporation

The investment firm lowered its holdings in the medical technology company by 25% in the fourth quarter.

Mar. 21, 2026 at 8:20am

Got story updates? Submit your updates here. ›

Confluence Investment Management LLC lowered its holdings in CONMED Corporation (NYSE:CNMD) by 25.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 91,164 shares of the company's stock after selling 30,374 shares during the period, representing approximately 0.29% of CONMED's outstanding shares.

Why it matters

This filing provides insight into the investment decisions of Confluence Investment Management, a prominent institutional investor. The reduction in their CONMED holdings could signal a shift in their outlook on the medical technology company's prospects.

The details

Confluence Investment Management reduced its stake in CONMED Corporation, a global medical technology company headquartered in Utica, New York. CONMED develops, manufactures, and markets a broad portfolio of surgical devices and accessories for minimally invasive procedures, with a focus on orthopedics, general surgery, gastroenterology, and gynecology.

  • Confluence Investment Management lowered its CONMED holdings in the fourth quarter of 2025.

The players

Confluence Investment Management LLC

An investment management firm that provides investment advisory services to institutional and individual clients.

CONMED Corporation

A global medical technology company that develops, manufactures, and markets a broad portfolio of surgical devices and accessories for minimally invasive procedures.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the shifting investment strategies of institutional investors like Confluence Investment Management, which could have implications for CONMED's future performance and market positioning within the medical technology industry.